Cargando…
Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
PURPOSE: To evaluate the role of intravitreal triamcinolone acetonide in patients who developed severe, visually compromising radiation maculopathy or progressed despite anti-angiogenic treatments. METHODS: An Institutional Review Board approved, consecutive, retrospective study from 2006 to 2009 of...
Autores principales: | Shah, Nisha V, Houston, Samuel K, Markoe, Arnold, Murray, Timothy G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788818/ https://www.ncbi.nlm.nih.gov/pubmed/24092966 http://dx.doi.org/10.2147/OPTH.S47684 |
Ejemplares similares
-
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
por: Shah, Nisha V, et al.
Publicado: (2012) -
Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review
por: Shah, Nisha V, et al.
Publicado: (2012) -
Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth
por: el Filali, Mariam, et al.
Publicado: (2008) -
Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi, Marcela, et al.
Publicado: (2013) -
Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
por: Houston, Samuel K, et al.
Publicado: (2013)